Prenatal diagnosis of genodermatoses: Current scope and future capabilities

International Journal of Dermatology

Volumn 49, Issue 4, 2010, Pages 353-361

  Luu, Minnelly ^a   Cantatore Francis, Julie L ^a   Glick, Sharon A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ECHOGRAPHY; FETUS CELL; GENE SEQUENCE; GENETIC ANALYSIS; GENODERMATOSIS; HUMAN; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; PATIENT CARE; PRENATAL DIAGNOSIS; REVIEW; SCREENING; SKIN BIOPSY; X LINKED ICHTHYOSIS;

EPIDERMOLYSIS BULLOSA; FETAL DISEASES; FETUS; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; POLYMORPHISM, GENETIC; PRENATAL DIAGNOSIS; SKIN DISEASES, GENETIC; ULTRASONOGRAPHY, PRENATAL;

EID: 77951987533     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04344.x     Document Type: Review

References (55)

1. Fassihi H, Eady RA, Mellerio JE. Prenatal diagnosis for severe inherited skin disorders: 25 years' experience. Br J Dermatol 2006, 154:106-113.
2. Golbus MS, Sagebiel RW, Filly RA. Prenatal diagnosis of congenital bullous ichthyosiform erythroderma (epidermolytic hyperkeratosis) by fetal skin biopsy. N Engl J Med 1980, 302:93-95.
3. Rodeck CH, Eady RA, Gosden CM. Prenatal diagnosis of epidermolysis bullosa letalis. Lancet 1980, 1:949-952.
4. Holbrook KA, Smith LT, Elias S. Prenatal diagnosis of genetic skin disease using fetal skin biopsy samples. Arch Dermatol 1993, 129:1437-1454.
5. Fuchs F, Riis P. Antenatal sex determination. Nature 1956, 177:330.
6. Nadler HL, Gerbie AB. Role of amniocentesis in the intrauterine detection of genetic disorders. N Engl J Med 1970, 282:596-599.
7. McKusick-Nathans Institute for Genetic Medicine 2000, http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim, Johns Hopkins University (Baltimore, MD) and US National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), Available at: (last accessed January 16, 2009)
8. Bonifas JM, Rothman AL, Epstein EH. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991, 254:1202-1205.
9. Shimizu H. Prenatal diagnosis of epidermolysis bullosa. Prenat Diagn 2006, 26:1260-1261.
10. Akiyama M, Sugiyama-Nakagiri Y, Sakai K. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 2005, 115:1777-1784.
11. Kelsell DP, Norgett EE, Unsworth H. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet 2005, 76:794-803.
12. Leech SN, Moss C. A current and online genodermatosis database. Br J Dermatol 2007, 156:1115-1148.
13. Pfendner EG, Nakano A, Pulkkinen L. Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat Diagn 2003, 23:447-456.
14. Cunniff C. Prenatal screening and diagnosis for pediatricians. Pediatrics 2004, 114:889-894.
15. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006, 1:612-616.
16. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995, 15:209-214.
17. Bruce S, Duffy JO, Wolf JE. Skin dimpling associated with midtrimester amniocentesis. Pediatr Dermatol 1984, 2:140-142.
18. Raimer SS, Raimer BG. Needle puncture scars from midtrimester amniocentesis. Arch Dermatol 1984, 120:1360-1362.
19. Ahluwalia J, Lowenstein E. Skin dimpling as a delayed manifestation of traumatic amniocentesis. Skinmed 2005, 4:323-324.
20. Braude P, Pickering S, Flinter F, Ogilvie CM. Preimplantation genetic diagnosis. Nat Rev Genet 2002, 3:941-953.
21. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2008, 90(Suppl. 5):S136-S143.
22. Verlinsky Y, Rechitsky S, Verlinsky O. Prepregnancy testing for single-gene disorders by polar body analysis. Genet Test 1999, 3:185-190.
23. Lewis CM, Pinel T, Whittaker JC, Handyside AH. Controlling misdiagnosis errors in preimplantation genetic diagnosis: a comprehensive model encompassing extrinsic and intrinsic sources of error. Hum Reprod 2001, 16:43-50.
24. Gutierrez-Mateo C, Sanchez-Garcia JF, Fischer J. Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. Fertil Steril 2008, Oct 18, [Epub ahead of print]
25. Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J Natl Cancer Inst Monogr 2005, 34:87-90.
26. Lietman SA, Goldfarb J, Desai N, Levine MA. Preimplantation genetic diagnosis for severe albright hereditary osteodystrophy. J Clin Endocrinol Metab 2008, 93:901-904.
27. Fassihi H, Renwick PJ, Black C, McGrath JA. Single cell PCR amplification of microsatellites flanking the COL7A1 gene and suitability for preimplantation genetic diagnosis of Hallopeau-Siemens recessive dystrophic epidermolysis bullosa. J Dermatol Sci 2006, 42:241-248.
28. Cserhalmi-Friedman PB, Tang Y, Adler A. Preimplantation genetic diagnosis in two families at risk for recurrence of Herlitz junctional epidermolysis bullosa. Exp Dermatol 2000, 9:290-297.
29. Fassihi H, Grace J, Lashwood A. Preimplantation genetic diagnosis of skin fragility-ectodermal dysplasia syndrome. Br J Dermatol 2006, 154:546-550.
30. Uitto J, Pfendner E, Jackson LG. Probing the fetal genome: progress in non-invasive prenatal diagnosis. Trends Mol Med 2003, 9:339-343.
31. Krabchi K, Gros-Louis F, Yan J. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001, 60:145-150.
32. Lo YM, Corbetta N, Chamberlain PF. Presence of fetal DNA in maternal plasma and serum. Lancet 16 1997, 350:485-487.
33. Lo YM, Tein MS, Lau TK. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
34. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 2004, 25(Suppl. A):S93-S101.
35. Costa JM, Benachi A, Gautier E. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001, 21:1070-1074.
36. Hyett JA, Gardener G, Stojilkovic-Mikic T. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005, 25:1111-1116.
37. Ding C, Chiu RW, Lau TK. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A 2004, 101:10762-10767.
38. Hahn S, Chitty LS. Noninvasive prenatal diagnosis: current practice and future perspectives. Curr Opin Obstet Gynecol 2008, 20:146-151.
39. van der Schoot CE, Hahn S, Chitty LS. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008, 13:63-68.
40. Finning K, Martin P, Summers J. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008, 336:816-818.
41. Poon LL, Leung TN, Lau TK, Lo YM. Circulating fetal RNA in maternal plasma. Ann N Y Acad Sci 2001, 945:207-210.
42. Lo YM, Tsui NB, Chiu RW. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13:218-223.
43. Watanabe T, Fujimori K, Kato K. Prenatal diagnosis for placental steroid salfatase deficiency with fluorescence in situ hybridization: a case of X-linked ichthyosis. J Obstet Gynaecol Res 2003, 29:427-430.
44. Aviram-Goldring A, Goldman B, Netanelov-Shapira I. Deletion patterns of the STS gene and flanking sequences in Israeli X-linked ichthyosis patients and carriers: analysis by polymerase chain reaction and fluorescence in situ hybridization techniques. Int J Dermatol 2000, 39:182-187.
45. Schoen E, Norem C, O'Keefe J. Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. Obstet Gynecol 2003, 102:167-172.
46. Glass IA, Lam RC, Chang T. Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes. Prenat Diagn 1998, 18:789-800.
47. Bongain A, Benoit B, Ejnes L. Harlequin fetus: three-dimensional sonographic findings and new diagnostic approach. Ultrasound Obstet Gynecol 2002, 20:82-85.
48. Vohra N, Rochelson B, Smith-Levitin M. Three-dimensional sonographic findings in congenital (harlequin) ichthyosis. J Ultrasound Med 2003, 22:737-739.
49. Holden S, Ahuja S, Ogilvy-Stuart A. Prenatal diagnosis of Harlequin ichthyosis presenting as distal arthrogryposis using three-dimensional ultrasound. Prenat Diagn 2007, 27:566-567.
50. Sepulveda W, Sandoval R, Carstens E. Hypohidrotic ectodermal dysplasia: prenatal diagnosis by three-dimensional ultrasonography. J Ultrasound Med 2003, 22:731-735.
51. Dugoff L, Thieme G, Hobbins JC. First trimester prenatal diagnosis of chondroectodermal dysplasia (Ellis-van Creveld syndrome) with ultrasound. Ultrasound Obstet Gynecol 2001, 17:86-88.
52. Lee K, Williams B, Roza K. PTPN11 analysis for the prenatal diagnosis of Noonan syndrome in fetuses with abnormal ultrasound findings. Clin Genet 2008, 75:190-4.
53. Baskin HJ. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol 2008, 38:936-952.
54. Pipitone S, Mongiovi M, Grillo R. Cardiac rhabdomyoma in intrauterine life: clinical features and natural history. A case series and review of published reports. Ital Heart J 2002, 3:48-52.
55. Jozwiak S, Kotulska K. Are all prenatally diagnosed multiple cardiac rhabdomyomas a sign of tuberous sclerosis? Prenat Diagn 2006, 26:867-869.